牛牛AI助理已提取核心訊息
Benjamin Hickey, President of RayzeBio Org., has filed an initial statement of beneficial ownership with the SEC, disclosing his stake in Bristol-Myers Squibb (BMY). The filing, dated February 26, 2024, indicates Hickey directly owns 780 shares of common stock and indirectly owns 91 shares through his spouse. Additionally, Hickey holds 30,236 restricted stock units (RSUs) that are set to vest in three equal installments starting February 1, 2025, with each RSU converting into one share of common stock upon vesting. The filing was completed on March 4, 2024, as per the requirements of Section 16(a) of the Securities Exchange Act of 1934.
Benjamin Hickey, President of RayzeBio Org., has filed an initial statement of beneficial ownership with the SEC, disclosing his stake in Bristol-Myers Squibb (BMY). The filing, dated February 26, 2024, indicates Hickey directly owns 780 shares of common stock and indirectly owns 91 shares through his spouse. Additionally, Hickey holds 30,236 restricted stock units (RSUs) that are set to vest in three equal installments starting February 1, 2025, with each RSU converting into one share of common stock upon vesting. The filing was completed on March 4, 2024, as per the requirements of Section 16(a) of the Securities Exchange Act of 1934.
RayzeBio Org. 總裁本傑明·希基已向美國證券交易委員會提交了初步的實益所有權聲明，披露了他在百時美施貴寶（BMY）的股份。這份日期爲2024年2月26日的文件顯示，希基直接擁有780股普通股，並通過其配偶間接擁有91股股票。此外，Hickey持有30,236個限制性股票單位（RSU），這些單位將從2025年2月1日起分三次等額歸屬，每個限制性股票單位在歸屬時轉換爲一股普通股。根據1934年《證券交易法》第16（a）條的要求，該文件於2024年3月4日完成。
RayzeBio Org. 總裁本傑明·希基已向美國證券交易委員會提交了初步的實益所有權聲明，披露了他在百時美施貴寶（BMY）的股份。這份日期爲2024年2月26日的文件顯示，希基直接擁有780股普通股，並通過其配偶間接擁有91股股票。此外，Hickey持有30,236個限制性股票單位（RSU），這些單位將從2025年2月1日起分三次等額歸屬，每個限制性股票單位在歸屬時轉換爲一股普通股。根據1934年《證券交易法》第16（a）條的要求，該文件於2024年3月4日完成。
有用
沒用